Molecular binding

Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy

Retrieved on: 
Thursday, July 11, 2019
Biotechnology, General Health, Health, Medical devices, Hospitals, Other Health, Chemistry, Organic compounds, Physical sciences, Biotin, Cofactors, Ureas, Molecular binding, Streptavidin

Veravas, Inc. , an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.

Key Points: 
  • Veravas, Inc. , an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
  • VeraTest Biotin and VeraPrep Biotin offer immediate solutions to address biotin interference in existing diagnostic tests.
  • VeraTest Biotin is a digital qualitative test that screens for biotin interference in less than five minutes.
  • This antibody retains a high binding affinity to conjugated biotin with a low binding affinity to free biotin, thus eliminating the impact of biotin interference on test results.

Applied DNA Signs Term Sheet with TheraCann International for Exclusive License of CertainT® Platform in Legal Cannabis and Hemp

Retrieved on: 
Tuesday, February 12, 2019
Technology, Security, Health, Alternative medicine, Other Health, Research, Other Science, Science, Biotechnology, Branches of biology, Natural sciences, Life sciences, DNA, Genetics, Helices, Molecular binding

In addition, Applied DNA will be the exclusive supplier of SigNature molecular tags, molecular tag application systems and molecular tag authentication systems to TheraCann for use within TheraCanns ETCH Biotrace system.

Key Points: 
  • In addition, Applied DNA will be the exclusive supplier of SigNature molecular tags, molecular tag application systems and molecular tag authentication systems to TheraCann for use within TheraCanns ETCH Biotrace system.
  • The term of the exclusive license to TheraCann is patent term for patented aspects, and 20 years for non-patented components.
  • Applied DNA cautions investors that the Term Sheet is a preliminary and non-binding document.
  • Founded in 2016, TheraCann International Benchmark Corporation offers a one-stop, full-service solution for the International cannabis marketplace.